No Data
Stocks that moved the previous day include part2 REVOLUTION, RSC, pluszero, etc.
Name of stock <code> 25-day closing price⇒Change from previous day *SHIFT＜3697＞ 13840 -825. Small and medium-sized growth stocks are dominant. * Kawasaki Kisen <9107> 2030 -90 Recently, shipping stocks have been bought due to good earnings from Maersk, etc. * IDOM <7599> 994 -28 Still wary of FSA's on-site inspections. * Rigaku Holdings <268A> 1130 Be aware of the large amount of absorption and start with a public price below the absorption amount. * Canon Inc.-spons adr <7751>
Emerging markets stock digest: Dai 247 soared, Baltes HD fell
<9556> INTLOOP 5070 -140 continues to rise but falls back. After the close of trading on the 24th, it was announced that a capital and business partnership agreement with Itochu Corporation was signed, causing an initial rise but turning to a decline due to market conditions. Through this partnership, further strengthening and accelerating collaboration as part of Itochu Corporation's digital business group, as well as providing exclusive organizations for the Itochu Group by the company, will enhance and expand existing businesses, create new businesses, and increase the long-term corporate value.
Active and newly listed stocks during the morning session.
*Nomi Bosai <6744> 2974 +173 reacts favorably to better-than-expected performance guidance revision. *Konica Minolta <4902> 593.3 +32.1 Macquarie Securities upgrades investment rating. *Nidec Corporation sponsored ADR <6594> 3127 +142.5 Is the development progressing based on a review following the previous day's briefing? *Watami <7522> 945 +21 rumored to acquire Subway's Japan operation, etc. *Shin-Etsu Polymer <7970> 1474 +21 In addition to the good financial results, there is also an expansion of return measures.
Hot stocks digest (morning session): Canon Inc-spons adr, Nomi Bosai, Rigaku etc.
<7751> Canon Inc. (7751) dropped sharply by 87 points. It announced its third-quarter financial results the previous day, with operating profit for the July-September period at 98.2 billion yen, an 18.8% increase year-on-year, falling below the market estimate of around 110 billion yen. As a result, the full-year forecast has been downwardly revised from the previous 465 billion yen to 455.5 billion yen, a 21.3% increase from the previous year. The revision is attributed to a reevaluation towards the assumption of a stronger yen. The market consensus of about 450 billion yen still remains at a level higher than before, despite the overall bearish market sentiment.
Kubota Pharmaceutical HD --- announces the progress of specific clinical research on the at-home and remote ophthalmic medical retinal monitoring equipment "eyeMO" amidst a standoff.
Stalemate. The progress of a specific clinical study using the at-home and remote ophthalmology retinal monitoring device 'eyeMO' was announced. In a specific clinical study being conducted at Shinshu University School of Medicine Hospital, the feasibility of the device was confirmed, and it has moved on to the step of considering whether monitoring using this device at patients' homes is possible. Rental income is expected in the same specific clinical study, but at this point, an objective calculation for the consolidated performance forecast for the fiscal year ending December 2024 has not been made.
Steady, nasdaq high and weak long-term US treasury yields provide support.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to show a strong performance. In the U.S. stock market on the 24th, the Dow Jones Industrial Average fell 140.59 points (-0.33%) to 42,374.36, marking the fourth consecutive decline. Concerns about the labor market receded as new jobless claims were lower than expected, and the decline in long-term interest rates supported stock prices. However, the Dow Jones was pushed down by profit-taking sales. The NASDAQ was lifted by the rise of electric car manufacturer Tesla (TSLA). Today's emerging markets
No Data
No Data